The Efficacy of Soluble Fibre Supplementation for the Treatment of Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05480696

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:27:09.006312+00:00

Published At

2024-11-12T00:00:00+00:00

Record Updated At

2024-11-12

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Non-Alcoholic Fatty Liver Disease", "Non Alcoholic Steatohepatitis", "Hepatic Steatosis"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2024-11-12"

protocolSection.identificationModule.nctId

"NCT05480696"

protocolSection.identificationModule.officialTitle

"The Efficacy of Soluble Fibre Supplementation for the Treatment of Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Non-Alcoholic Fatty Liver Disease (protocolSection.conditionsModule.conditions)
• Non Alcoholic Steatohepatitis (protocolSection.conditionsModule.conditions)
• Hepatic Steatosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.